India, July 4 -- Odisha-based Serendipity Space, a pioneering space-tech company developing microgravity-based pharmaceutical manufacturing solutions, has raised its pre-seed round fromCampus Fund.

The investment will accelerate the company's mission to transform drug development by leveraging space-based crystallisation technology through its proprietary satellite platform and autonomous pharmaceutical crystallization module called 'Alchemy'.

Serendipity Space addresses one of the pharmaceutical industry's biggest bottlenecks - the inability to produce high-quality protein and drug crystals on Earth due to gravity-induced defects. The team combines deep space systems engineering expertise with pharmaceutical development experience by w...